Maravai LifeSciences Holdings, Inc.

Maravai LifeSciences Holdings, Inc.verified

MRVI

Price:

$5.37

Market Cap:

$761.70M

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and ...[Read more]

Industry

Biotechnology

IPO Date

2020-11-20

Stock Exchange

NASDAQ

Ticker

MRVI

The Enterprise Value as of December 2024 (TTM) for Maravai LifeSciences Holdings, Inc. (MRVI) is 744.62M

According to Maravai LifeSciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 744.62M. This represents a change of -27.90% compared to the average of 1.03B of the last 4 quarters.

Maravai LifeSciences Holdings, Inc. (MRVI) Historical Enterprise Value (quarterly & annually)

How has MRVI Enterprise Value performed in the past?

The mean historical Enterprise Value of Maravai LifeSciences Holdings, Inc. over the last ten years is 2.80B. The current 744.62M Enterprise Value has changed 2.56% with respect to the historical average. Over the past ten years (40 quarters), MRVI's Enterprise Value was at its highest in in the March 2022 quarter at 9.10B. The Enterprise Value was at its lowest in in the June 2020 quarter at 0.

Quarterly (TTM)
Annual

Average

2.80B

Median

3.02B

Minimum

900.07M

Maximum

4.79B

Maravai LifeSciences Holdings, Inc. (MRVI) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Maravai LifeSciences Holdings, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 56.34%

Maximum Annual Enterprise Value = 4.79B

Minimum Annual Increase = -61.70%

Minimum Annual Enterprise Value = 900.07M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023900.07M-50.96%
20221.84B-61.70%
20214.79B56.34%
20203.07B-5.69%
20193.25B9.31%

Maravai LifeSciences Holdings, Inc. (MRVI) Average Enterprise Value

How has MRVI Enterprise Value performed in the past?

The current Enterprise Value of Maravai LifeSciences Holdings, Inc. (MRVI) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

2.51B

5-year avg

2.77B

10-year avg

2.80B

Maravai LifeSciences Holdings, Inc. (MRVI) Enterprise Value vs. Peers

How is MRVI’s Enterprise Value compared to its peers?

Maravai LifeSciences Holdings, Inc.’s Enterprise Value is less than Roivant Sciences Ltd. (6.51B), less than Krystal Biotech, Inc. (4.37B), less than Prometheus Biosciences, Inc. (9.30B), less than Akero Therapeutics, Inc. (1.77B), less than Apellis Pharmaceuticals, Inc. (4.20B), less than Halozyme Therapeutics, Inc. (7.32B), less than Agios Pharmaceuticals, Inc. (1.83B), less than Insmed Incorporated (13.14B), less than Cerevel Therapeutics Holdings, Inc. (8.24B), less than Ultragenyx Pharmaceutical Inc. (3.97B), greater than Alector, Inc. (179.63M), less than Legend Biotech Corporation (6.14B), less than Ascendis Pharma A/S (7.97B), less than Cytokinetics, Incorporated (6.51B), less than Edgewise Therapeutics, Inc. (2.87B), less than Amicus Therapeutics, Inc. (3.14B), less than Incyte Corporation (11.99B), less than Denali Therapeutics Inc. (3.05B), less than argenx SE (36.25B), less than Harmony Biosciences Holdings, Inc. (1.75B), greater than Arbutus Biopharma Corporation (577.87M), less than Immunovant, Inc. (3.32B), less than Arcutis Biotherapeutics, Inc. (1.83B), less than Protagonist Therapeutics, Inc. (2.35B),

Build a custom stock screener for Maravai LifeSciences Holdings, Inc. (MRVI) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Maravai LifeSciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Maravai LifeSciences Holdings, Inc. (MRVI) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Maravai LifeSciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Maravai LifeSciences Holdings, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Maravai LifeSciences Holdings, Inc. (MRVI)?

What is the 3-year average Enterprise Value for Maravai LifeSciences Holdings, Inc. (MRVI)?

What is the 5-year average Enterprise Value for Maravai LifeSciences Holdings, Inc. (MRVI)?

How does the current Enterprise Value for Maravai LifeSciences Holdings, Inc. (MRVI) compare to its historical average?